Title:
PROPHYLACTIC OR THERAPEUTIC AGENT FOR RETINAL DISEASES COMPRISING POLYALKYLENE GLYCOL AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2010/035768
Kind Code:
A1
Abstract:
The object aims to search novel applications of a polyalkylene glycol for medical purposes.
Polyethylene glycol (PEG) inhibits photoreceptor cell death in light-induced damage model mice and rats. This means that a polyalkylene glycol such as PEG can prevent retinal disorders. Therefore, a polyalkylene glycol is useful as a prophylactic or therapeutic agent for retinal diseases (including retinal disorders caused by ophthalmic surgery).
Inventors:
HIRAI SHIN-ICHIRO (JP)
MATSUSHITA TOKIYOSHI (JP)
HABASHITA SAYO (JP)
FUJITA YUKIE (JP)
YOSHIDA ATSUSHI (JP)
MATSUSHITA TOKIYOSHI (JP)
HABASHITA SAYO (JP)
FUJITA YUKIE (JP)
YOSHIDA ATSUSHI (JP)
Application Number:
PCT/JP2009/066586
Publication Date:
April 01, 2010
Filing Date:
September 25, 2009
Export Citation:
Assignee:
SANTEN PHARMACEUTICAL CO LTD (JP)
HIRAI SHIN-ICHIRO (JP)
MATSUSHITA TOKIYOSHI (JP)
HABASHITA SAYO (JP)
FUJITA YUKIE (JP)
YOSHIDA ATSUSHI (JP)
HIRAI SHIN-ICHIRO (JP)
MATSUSHITA TOKIYOSHI (JP)
HABASHITA SAYO (JP)
FUJITA YUKIE (JP)
YOSHIDA ATSUSHI (JP)
International Classes:
A61K31/77; A61P27/02
Domestic Patent References:
| WO2001039765A2 | 2001-06-07 | |||
| WO2007095178A2 | 2007-08-23 |
Foreign References:
| JP2006516288A | 2006-06-29 | |||
| JP2001520979A | 2001-11-06 |
Attorney, Agent or Firm:
HIBI, Norihiko et al. (JP)
Norihiko Hibi (JP)
Norihiko Hibi (JP)
Download PDF: